SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Alphabet Inc. for the reporting period ending March 31, 2018. The document discloses equity securities held by the reporting manager at the end of the quarter. It does not contain Alphabet's own financial performance data (revenue, profit, or cash flow) but rather details its investment portfolio in other public companies.
Key Financial Metrics and Portfolio Holdings
The filing lists specific equity positions held by Alphabet Inc. as of the reporting date. The table below summarizes the disclosed holdings, including the issuer, title of class, CUSIP, number of shares, and value (in thousands).
| Issuer | Title of Class | Shares | Value ($000s) | Voting Authority |
|---|---|---|---|---|
| Arcus Biosciences Inc | COM | 77,969 | 5,049,786 | Sole |
| Armo Biosciences Inc | COM | 45,442 | 1,214,700 | Sole |
| Arris Intl Inc | SHS | 257,822 | 9,703,500 | Shared |
| Arsanis Inc | COM | 61,990 | 451,362 | Sole |
| Cloudera Inc | COM | 22,905 | 1,061,420 | Sole |
| Denali Therapeutics Inc | COM | 11,158 | 566,666 | Sole |
| Dropbox Inc | CL A | 407 | 13,033 | Sole |
| Snap Inc | CL A | 41,556 | 2,618,548 | Sole |
| Spero Therapeutics Inc | COM | 15,853 | 1,112,473 | Sole |
| Square Inc | CL A | 1,446 | 29,400 | Shared |
| Zscaler Inc | COM | 78,275 | 2,788,560 | Sole |
Note: The filing text does not provide a clear value for Alphabet's total portfolio value, revenue, profit, cash flow, margins, debt, or liquidity. These metrics are not applicable to a Form 13F filing, which focuses solely on disclosed holdings.
Material Changes and Guidance
The filing text does not provide data for the prior comparable period, preventing a calculation of material changes in holdings. Additionally, there is no management commentary, guidance, outlook, or discussion of risks and contingencies included in this specific document.
Important Facts for Investor Verification
- Filing Type: This is a disclosure of holdings (Form 13F), not a financial performance report (10-K or 10-Q).
- Reporting Entity: The data reflects investments made by Alphabet Inc., not Alphabet's own operational results.
- Portfolio Composition: The disclosed holdings are heavily weighted toward technology and biotechnology sectors (e.g., Arcus Biosciences, Arris Intl, Snap Inc, Zscaler).
- Voting Authority: Alphabet holds "Sole" voting authority for most positions, with "Shared" authority noted for Arris Intl Inc and Square Inc.
- Data Limitations: This table represents a subset of holdings; it does not list all securities held by the company, only those meeting specific disclosure thresholds or selected for this specific table view.